m(i)RNA based precision onco-diagnostics using serum exosomes of breast and prostate cancer samples.
Identifying novel stage-specific molecular markers for the early diagnosis of non-small cell lung cancer
personalized tumour diagnostics of melanoma (combining genomics, transcriptomics and proteomics approaches)
Transcription related cellular responses induced by DNA damage
ITCH E3 ubiquitin ligase, a novel fine-tune regulator between transcription and DNA repair
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.